Abiopharma

Nexera: KeepZone AI Enters into White Label Agreement to Develop its AI-Based Voice Communication Decision Support System

BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting

Volition Launches rNuQ™ Webshop Broadening Product Range

TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region

Swvl Announces FY 2025 Results; Revenue Up 41% to $24.2 million; Net Income $1.3 million; NDR of 128%; GCC Revenue Up 122%

Neurogene Appoints Christy Shafer as Chief Commercial Officer and Christine Mikail, J.D., to Board of Directors

Palvella Therapeutics to Present QTORIN™ Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026

Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region

BWXT Bolsters American Nuclear Manufacturing Capability With Strategic Acquisition

Dragonfly Energy Secures Multi-Million Dollar Order from Stevens Transport, Marking a Major Commercial Milestone